|
 |
| home > ebr > autumn 2003 > a concept for the improvement of biopharmaceutical process development - the austrian center of biopharmaceutical technology |
|
|
 PUBLICATIONS |
European BioPharmaceutical Review
|
| The biopharmaceutical industry is an innovative industrial sector considered to have a great potential for the generation of hi-tech jobs and added value products. At the same time the development of new products and processes is connected with long development cycles and, as a consequence, with high costs and risks. In order to improve this situation, industry and university institutes in Austria have joined forces to realise powerful interdisciplinary synergies by implementing a competence centre for biopharmaceutical technology. This approach integrates research and development strategies in all relevant scientific and technological fields resulting in a faster and more efficient optimisation of biopharmaceutical production processes. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
EuroBiopartnering 2008
7-9 October 2008, Paris, France
EuroBiOpartnering
2008 gives you the unique opportunity to meet the relevant decision makers and
opinion leaders from the international biotech community and offers you 3 days
of partnering opportunities including one-to-one meetings, company presentations
and further networking activities…
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
